NRP2 and pancreatic neoplasm: It also promotes the progression of pancreatic cancer through augmentation of Wnt/β-catenin signaling, and neuroblastoma through inhibition of glia-derived neurotrophic factor (GDNF) and neuropilin 2 (NRP2) expression [10, 11].